Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Fresh Tracks Therapeutics Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by righand2on Jun 21, 2017 10:38am
202 Views
Post# 26387128

RE:RE:Keyera

RE:RE:Keyera
DoubleGG wrote: I have heard that they have excusive deal with Keyera.


BBI said they were negotiating for 90 mmcf/d of processing capacity. Keyera's plant is 150 mmcf/d for startup in mid 2019, just for the first phase, with an additional 150 mmcf/d expansion planned.
And if you look at BBI's Feb 21st news release, they are only talking about 30 mmcf/d at the time the Keyear plant comes on stream.
BBI "might" be the company Keyera is talking about, but the numbers and BBI's own news releases say they are not.
Hopefully, BBI will update shareholders in the Q3 report.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities